Legal status · United Kingdom
Is Mecasermin legal in the United Kingdom?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Mecasermin is an approved medicine in the United Kingdom. Its legal category is "Licensed, prescription only (MHRA)". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.
- People given it
- 76
- Found nothing
- 0
Legal category
Licensed, prescription only (MHRA)
Licensed for the same use in children. Europe first approved it in August 2007 under exceptional circumstances, a special route used because so few patients exist to study.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
Mecasermin in the United Kingdom at a glance
| Legal category | Licensed, prescription only (MHRA) |
|---|---|
| Note | Licensed for the same use in children. Europe first approved it in August 2007 under exceptional circumstances, a special route used because so few patients exist to study. |
| MHRA approval status | Approved by MHRA for the use on its label |
| Studies in people | 5 of 5 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the Mecasermin profile. We checked them against Medicines and Healthcare products Regulatory Agency (MHRA) listings on the reviewed date.
What this means
- 01
MHRA has approved Mecasermin for at least one use named on its label. So a proper pharmacy-grade product exists in the United Kingdom, and pharmacies hand it out on prescription.
- 02
Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.
- 03
Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.
What Mecasermin is
An approved medicine, but only for a rare condition in children. In 76 children with a severe shortage of IGF-1, growth sped up from 2.8 cm a year to 8.0 cm a year in the first year, and 49 percent had low blood sugar. Children followed to the end of puberty moved a good way up the height chart but stayed well short of average.
Mecasermin is a lab-made copy of human IGF-1, the finished 70 amino acid form of the hormone. It is given as a shot under the skin, twice a day with food.
How it works: Mecasermin locks onto the IGF-1 receptor on cells. That switches on growth signals inside the cell, called PI3K/Akt and MAPK.
Approval history: FDA-approved. INCRELEX (mecasermin), BLA 021839, made by Ipsen, first approved 30 August 2005, prescription only. It is for children who are not growing because of a severe IGF-1 shortage that is not caused by low growth hormone. It is also for children missing the growth hormone gene whose immune system has started blocking growth hormone treatment. It is not approved for adults, for age-related muscle loss, for recovery or for any performance use.
How MHRA treats this kind of product
Licenses medicines for sale in the UK. A compound without a licence to be sold (a marketing authorisation) is an unlicensed medicine. The law only lets it reach people through a prescriber, under the specials scheme (unlicensed medicines made for one patient's needs). It cannot be sold as a research product.
The legal category above is how The Longevity Archive reads Medicines and Healthcare products Regulatory Agency listings for Mecasermin on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
Mecasermin in sport and the military
Whether Mecasermin is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United Kingdom. Before you compete or get tested, look up Mecasermin by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
Mecasermin in other countries
Frequently asked questions
Is Mecasermin legal in the United Kingdom?
Yes. Mecasermin is an approved medicine in the United Kingdom. Its legal category is "Licensed, prescription only (MHRA)". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile. Note: Licensed for the same use in children. Europe first approved it in August 2007 under exceptional circumstances, a special route used because so few patients exist to study.
Can I buy Mecasermin in the United Kingdom?
Only with a prescription. In the United Kingdom, Mecasermin has the legal category "Licensed, prescription only (MHRA)". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: Licensed for the same use in children. Europe first approved it in August 2007 under exceptional circumstances, a special route used because so few patients exist to study.
Is Mecasermin MHRA approved?
Yes, for the use on its label. In the United Kingdom, Mecasermin has the legal category "Licensed, prescription only (MHRA)". For comparison, its US FDA status is: FDA-approved. INCRELEX (mecasermin), BLA 021839, made by Ipsen, first approved 30 August 2005, prescription only. It is for children who are not growing because of a severe IGF-1 shortage that is not caused by low growth hormone. It is also for children missing the growth hormone gene whose immune system has started blocking growth hormone treatment. It is not approved for adults, for age-related muscle loss, for recovery or for any performance use.. On the evidence, 1 completed human trial is cited on its profile.
Related compounds in the United Kingdom
Full research profile
How Mecasermin works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
Mecasermin profileThis page is general information about the legal status of Mecasermin in the United Kingdom, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Medicines and Healthcare products Regulatory Agency or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.